Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

Subtypes of Breast Cancer
Erasmo Orrantia‐Borunda, Patricia Anchondo-Nuñez, Lucero Evelia Acuña-Aguilar, et al.
Breast Cancer (2022), pp. 31-42
Open Access | Times Cited: 172
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
Hibah Shaath, Radhakrishnan Vishnubalaji, Ramesh Elango, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 325-345
Open Access | Times Cited: 95
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 23
SNHG family lncRNAs: key players in the breast cancer progression and immune cell’s modulation
Mohamed J. Saadh, Junainah Abd Hamid, H. Malathi, et al.
Experimental Cell Research (2025), pp. 114531-114531
Closed Access | Times Cited: 1
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
Ioana-Miruna Stanciu, Andreea Paroşanu, Cristina Orlov‐Slavu, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 987-987
Open Access | Times Cited: 22
Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes
Radhakrishnan Vishnubalaji, Nehad M. Alajez
Cells (2023) Vol. 12, Iss. 8, pp. 1182-1182
Open Access | Times Cited: 20
Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist’s Perspective
Giuseppe Angelico, Giuseppe Broggi, Giordana Tinnirello, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4479-4479
Open Access | Times Cited: 16
A Review of the Advancements in Targeted Therapies for Breast Cancer
John Kessellie Jallah, Tuward J. Dweh, Ashish Anjankar, et al.
Cureus (2023)
Open Access | Times Cited: 16
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer
Oliver Treeck, Silke Haerteis, Olaf Ortmann
Cancers (2023) Vol. 15, Iss. 6, pp. 1632-1632
Open Access | Times Cited: 15
Multifaced roles of the long non-coding RNA DRAIC in cancer progression
Kouhei Sakurai, Hiroyasu Ito
Life Sciences (2024) Vol. 343, pp. 122544-122544
Closed Access | Times Cited: 5
Identification of Interpretable Clusters and Associated Signatures in Breast Cancer Single-Cell Data: A Topic Modeling Approach
M. Gabriele, Filippo Valle, Emmanuel Barillot, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1350-1350
Open Access | Times Cited: 5
A Regulatory Circuits Analysis Tool, “miRCuit,” Helps Reveal Breast Cancer Pathways: Toward Systems Medicine in Oncology
Begum Karaoglu, Bala Gür Dedeoğlu
OMICS A Journal of Integrative Biology (2025)
Closed Access
Bardoxolone displays potent activity against triple negative breast cancer by inhibiting the TRIP13/STAT3 circuit
Jianhua Deng, Hongyue Li, Ziyang Liu, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors
Richard Khanyile, Talent Chipiti, Rodney Hull, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 808-808
Open Access
Beyond traditional biopsies: the emerging role of ctDNA and MRD on breast cancer diagnosis and treatment
Hussein Sabit, Mohamed S. Attia, Nouran Mohamed, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell Line
Isabel Lemos, Catarina Freitas-Dias, Ana Hipólito, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 227-227
Open Access
Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study
Miklós Darida, Gábor Rubovszky, Zoltán Kiss, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment
Zhengfei Guo, Rui Dong, Y. Wu, et al.
Oncogene (2025)
Closed Access
Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression
Ramesh Elango, Vishnubalaji Radhakrishnan, Sameera Rashid, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment Resistance
Mohammad Yasin Zamanian, Maryam Golmohammadi, Ali Akil Al-Alak, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 16, pp. 1819-1828
Closed Access | Times Cited: 6
Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
Cansu E. Önder, Teresa J. Ziegler, R Becker, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3602-3602
Open Access | Times Cited: 6
LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities
Radhakrishnan Vishnubalaji, Ramesh Elango, Nehad M. Alajez
Non-Coding RNA (2022) Vol. 8, Iss. 4, pp. 44-44
Open Access | Times Cited: 10
Locally Advanced Adenoid Cystic Carcinoma of the Breast—A Case Report with a Review of the Literature
Joanna Rypel, Paulina Kubacka, Joanna Mykała-Cieśla, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 2005-2005
Open Access | Times Cited: 4
Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data
Yisheng Huang, Liling Qiu, Xiaoye Liang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 7
Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics
Mudassir Hassan, Lütfi Tutar, Duygu Sari, et al.
Translational Oncology (2024) Vol. 47, pp. 102055-102055
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top